The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 06, 2024
Filed:
May. 02, 2018
Applicant:
Nektar Therapeutics, San Francisco, CA (US);
Inventors:
Saul Kivimae, San Francisco, CA (US);
Marlene Hennessy, San Jose, CA (US);
Neel K. Anand, San Mateo, CA (US);
Haiying Cai, Cupertino, CA (US);
Bo-Liang Deng, San Ramon, CA (US);
Zhongxu Ren, Foster City, CA (US);
Bhalchandra V. Joshi, Madison, AL (US);
Assignee:
Nektar Therapeutics, San Francisco, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 31/4745 (2006.01); A61K 39/00 (2006.01); A61K 47/60 (2017.01); A61P 35/00 (2006.01); C07K 14/55 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2878 (2013.01); A61K 31/4745 (2013.01); A61K 47/60 (2017.08); A61P 35/00 (2018.01); C07K 14/55 (2013.01); A61K 2039/505 (2013.01);
Abstract
Provided is a method of administering to a patient having cancer: (a) a 4-1BB agonist; (b) an IL-2Rβ-activating amount of a long-acting, IL-2Rβ-selective agonist; and/or (c) a toll-like receptor agonist, as well as related compositions, kits and compositions.
Kivimae, Saul. (2024). Immunotherapeutic tumor treatment method (U.S. Patent No. 12054553). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12054553
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile